National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

5-hydroxytryptamine 3 receptor antagonist (.5-hy-DROK-see-TRIP-tuh-meen 3 reh-SEP-ter an-TA-guh-nist)

 A type of drug used to treat certain types of irritable bowel syndrome and relieve nausea and vomiting. It is a type of antiemetic. Also called 5-HT3 receptor antagonist and type 3 serotonin receptor antagonist.



Previous Definitions:5-fluorouracil, 5-FU, 5-HT3 receptor antagonist, 5-hydroxyindoleacetic acid, 5-hydroxytryptamine
Next Definitions:506U78, 5Q minus syndrome, 5Q- syndrome, 6-hydroxymethylacylfulvene, 852A

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov